Notchi and TGF21 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells

Blood

Volumn 112, Issue 5, 2008, Pages 1813-1821

  Samon, Jeremy B ^a   Champhekar, Ameya ^a,b   Minter, Lisa M ^a   Telfer, Janice C ^a   Miele, Lucio ^a   Fauq, Abdul ^c   Das, Pritam ^c   Golde, Todd E ^c   Osborne, Barbara A ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GAMMA SECRETASE INHIBITOR; NOTCH1 RECEPTOR; PROTEIN CSL; SMAD PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ALANINE; AZEPINE DERIVATIVE; DRUG DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; MUSCLE PROTEIN; N2 ((2S) 2 (3,5 DIFLUOROPHENYL) 2 HYDROXYETHANOYL) N1 ((7S) 5 METHYL 6 OXO 6,7 DIHYDRO 5H DIBENZO(B,D)AZEPIN 7 YL) L ALANINAMIDE; N2-((2S)-2-(3,5-DIFLUOROPHENYL)-2-HYDROXYETHANOYL)-N1-((7S)-5-METHYL-6-OXO-6,7-DIHYDRO-5H-DIBENZO(B,D)AZEPIN-7-YL)-L-ALANINAMIDE; NOTCH1 PROTEIN, MOUSE; PRIMER DNA; PROTEINASE INHIBITOR; SECRETASE; SMPX PROTEIN, MOUSE;

ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GENE TARGETING; HEPATITIS; HISTOLOGY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ALANINE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; AZEPINES; BASE SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA PRIMERS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE PROTEINS; PROTEASE INHIBITORS; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; SMAD PROTEINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 52649179291     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-144980     Document Type: Article

References (51)

1. Osborne BA. Minter LM. Notch signalling during peripheral T-cell activation and differentiation. Nat Rev Immunol. 2007;7:64-75.
2. Parks AL, Curtis D. Presenilin diversifies its portfolio. Trends Genet. 2007;23:140-150.
3. Aster JG. Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. Int J Hematol. 2005;82:295-301.
4. Siemers ER, Quinn JF. Kaye J. et al. Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology. 2006;66:602-604.
5. Amsen D, Antov A, Jankovic D, et al. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity. 2007;27:89-99.
6. Fang TC, Yashiro-Ohtani Y, Del Bianco C, Knoblock DM, Blacklow SC, Pear WS. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity. 2007;27:100-110.
7. Minter LM, Turley DM, Das P, et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat Immunol. 2005;6:680-688.
8. Anastasi E, CampeseAF, Bellavia D, et al. expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J Immunol. 2003;171:4504-4511.
9. Vigouroux S, Yvon E, Wagner HJ, et al. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes. J Virol. 2003;77:10872-10880.
10. Yvon ES. Vigouroux S. Rousseau RF. et al. Over-expression of the Notch ligand, Jagged-1. induces alloantigen-specific human regulatory Tcells. Blood. 2003;102:3815-3821.
11. Kared H, Adle-Biassette H, Fois E, et al. Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. Immunity. 2006;25: 823-834.
12. Hori S, Nomura T. Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-1061.
13. Chen W, Jin W, Hardegen N, etal. Conversion of peripheral CD4+CD25-naive Tcells to CD4+CD25+ regulatory Tcells byTGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198:1875-1886.
14. Fu S. Zhang N. YoppAC, etal. TGF-beta induces Foxp3 + T-regulatory cells from CD4+ CD25-precursors. Am JTransplant. 2004:4:1614-1627.
15. Rao PE, PetroneAL, Ponath PD. Differentiation and expansion of Tcells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-{beta}. J Immunol. 2005;174:1446-1455.
16. Li MO. Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory Tcell-dependent and -independent mechanisms. Immunity. 2006;25:455-471.
17. Marie JC, Letterio JJ, Gavin M, RudenskyAY. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory Tcells. J Exp Med. 2005;201:1061-1067.
18. Shull MM, Ormsby I, KierAB, et al. Targeted disruption of the mouse transforming growth factorbeta 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
19. Lahl K, LoddenkemperC, Drouin C, et al. Selective depletion of Foxp3+ regulatory Tcells induces a scurfy-like disease. J Exp Med. 2007; 204:57-63.
20. Sharma R, Jarjour WN, Zheng L Gaskin F, Fu SM. Ju ST. Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice. J Autoimmun. 2007;29:10-19.
21. Blokzijl A, Dahlqvist C, Reissmann E, et al. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol. 2003;163:723-728.
22. Sun Y, Lowther W, Kato K, et al. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene. 2005;24: 5365-5374.
23. Cheng P, Zlobin A. VolginaV, etal. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol. 2001;167:4458-4467.
24. Jinnin M, Ihn H, Tamaki K. Characterization of SIS3. a novel specific inhibitor of Smad3. and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 2006;69:597-607.
25. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML. Greene Ml, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008;9:194-202.
26. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential forTGF-beta to convert naive CD4+CD25-cells to CD25 + Foxp3+ regulatory Tcells and for expansion of these cells. J Immunol. 2007;178:2018-2027.
27. Hill JA, Feuerer M, Tash K, et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity. 2007;27:786-800.
28. Sugimoto N, Oida T. Hirota K, et al. Foxp3-dependent and -independent molecules specific for CD25 + CD4+ natural regulatory Tcells revealed by DNA microarray analysis. Int Immunol. 2006;18:1197-1209.
29. Mantel PY, Ouaked N. Ruckert B, et al. Molecular mechanisms underlying FOXP3 induction in human Tcells. J Immunol. 2006;176:3593-3602.
30. Schouwey K, Delmas V, Lame L, et al. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev Dyn. 2007;236:282-289.
31. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al. Human CD4+ CD25hi Foxp3+ regulatory Tcells are derived by rapid turnover of memory populations in vivo. J Clin Invest. 2006;116:2423-2433.
32. Akbar AN. Vukmanovic-Stejic M. Taams LS. Macallan DC. The dynamic co-evolution of memory and regulatory CD4+ Tcells in the periphery. Nat Rev Immunol. 2007;7:231-237.
33. Zamurovic N, Cappellen D, Rohner D, Susa M. Coordinated activation of notch. Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis: notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem. 2004;279:37704-37715.
34. Seo S, Fujita H, Nakano A, Kang M, Duarte A, Kume T. The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev Biol. 2006;294:458-470.
35. Kalinichenko VV, Gusarova GA, Kim IM, et al. Foxf1 haploinsufficiency reduces Notch-2 signaling during mouse lung development. Am J Physiol Lung Cell Mol Physiol. 2004;286:L521-530.
36. Kitamura T, Kitamura Yl, Funahashi Y, et al. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest. 2007;117:2477-2485.
37. Seoane J, Le HV, Shen L, Anderson SA, Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 2004;117:211-223.
38. Asano N, Watanabe T Kitani A, Fuss IJ, Strober W. Notchi signaling and regulatory T cell function. J Immunol. 2008;180:2796-2804
39. Ostroukhova M, Qi Z, Oriss TB, Dixon-McCarthy B, Ray P, Ray A. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest. 2006;116:996-1004.
40. Oswald F, Tauber B. DobnerT et al. p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol. 2001;21:7761-7774.
41. Shen X, Hu PP, Liberati NT, Datto MB, Frederick JP. Wang XF. TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell. 1998; 9:3309-3319.
42. Takizawa T, Ochiai W, Nakashima K, Taga T Enhanced gene activation by Notch and BMP signaling cross-talk. Nucleic Acids Res. 2003;31: 5723-5731.
43. Krejcf A, Bray S. Notch activation stimulates transient and selective binding of Su(H)/CSLto target enhancers. Genes Dev. 2007;21:1322-1327.
44. Schramm C, Huber S, Protschka M, et al. TGF-beta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. Int Immunol. 2004;16:1241-1249.
45. Godfrey VL, Wilkinson JE, Rinchik EM, Russell LB. Fatal lymphoreticular disease in the scurfy (sf) mouse requires Tcells that mature in a sf thymic environment: potential model for thymic education. Proc Natl Acad Sci U S A. 1991;88:5528-5532.
46. Tournoy J, Bossuyt X, Snellinx A. et al. Partial loss of presenilins causes seborrheic keratosis and autoimmune disease in mice. Hum Mol Genet. 2004;13:1321-1331.
47. Kremer M, Perry AW, Milton RJ, Rippe RA, Wheeler MD, Hines IN. Pivotal role of Smad3 in a mouse model of T cell-mediated hepatitis. Hepatology. 2008;47:113-126.
48. Sakaguchi K, Kitano M, Nishimura M, et al. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis. Hepatogastroenterology. 2004;51:1780-1783.
49. Schramm C, Protschka M, Kohler HH, et al. Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2003;284:G525-G535.
50. Longhi MS, Hussain MJ, Mitry RR, et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol. 2006;176:4484-4491.
51. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 2007;445:766-770.